BioVentrix Announces First Patient at Cardiovascular Institute of the South Successfully Treated in IDE Study of Revivent TC™ TransCatheter Ventricular Enhancement Treatment

March 12, 2018

Responsive image

SAN RAMON, Calif., and HOUMA, La., March 12, 2018 /PRNewswire/ — BioVentrix, Inc., a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced successful treatment of the first patient at the Cardiovascular Institute of the South in the…

Category: Precious Metals